BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4521198)

  • 21. [Protective effect of buflomedil hydrochloride on erythrocyte sickling. In vitro study].
    Briguglio F; Briguglio E; Di Marco V
    Minerva Med; 1986 Feb; 77(7-8):249-62. PubMed ID: 3951731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of erythrocyte sickling in vitro by pyridoxal.
    Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
    J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood-oxygen affinity and sickling in sickle cell disease: effect of prior deoxygenation.
    Sinet M; Pocidalo JJ
    J Lab Clin Med; 1981 Oct; 98(4):492-9. PubMed ID: 6793678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sickle cell anemia and the affinity of the blood for oxygen].
    Pocidalo JJ; Sinet M
    C R Seances Soc Biol Fil; 1979; 173(2):303-13. PubMed ID: 159755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deoxyhemoglobin S: solubility vs. erythrocyte sickling.
    Vedvick TS; Koenig HM; Itano HA
    Clin Biochem; 1975 Aug; 8(4):288-90. PubMed ID: 1157297
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyridoxal phosphate as an antisickling agent in vitro.
    Kark JA; Tarassoff PG; Bongiovanni R
    J Clin Invest; 1983 May; 71(5):1224-9. PubMed ID: 6853710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of erythrocyte sickling by cystamine, a thiol reagent.
    Hassan W; Beuzard Y; Rosa J
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3288-92. PubMed ID: 135260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between human hemoglobins: sickling and related phenomena.
    Bookchin RM; Nagel RL
    Semin Hematol; 1974 Oct; 11(4):577-95. PubMed ID: 4608956
    [No Abstract]   [Full Text] [Related]  

  • 30. Deoxygenation permeabilizes sickle cell anaemia red cells to magnesium and reverses its gradient in the dense cells.
    Ortiz OE; Lew VL; Bookchin RM
    J Physiol; 1990 Aug; 427():211-26. PubMed ID: 2213597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes.
    Diederich D
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168
    [No Abstract]   [Full Text] [Related]  

  • 32. [Recent findings in the pharmacological manipulations of oxygen-hemoglobin affinity and their applications (author's transl].
    Kugimiya Y
    Kokyu To Junkan; 1978 May; 26(5):412-20. PubMed ID: 663427
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 effects on cation flux in sickle erythrocyte ghosts.
    Rabinowitz IN; Wolf PL; Berman S; Shikuma N; Edwards P
    Prostaglandins; 1975 Apr; 9(4):545-55. PubMed ID: 1153810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sickling in vitro of reticulocytes from patients with sickle cell disease at venous oxygen tension.
    Horiuchi K; Onyike AE; Osterhout ML
    Exp Hematol; 1996 Jan; 24(1):68-76. PubMed ID: 8536795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation.
    Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP
    J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyanate as an inhibitor of red-cell sickling.
    Cerami A
    N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520
    [No Abstract]   [Full Text] [Related]  

  • 38. Modification of the oxygen affinity and intracellular hemoglobin concentration of normal and sickle cells by means of an osmotic pulse.
    Franco RS; Barker RL
    J Lab Clin Med; 1989 Jan; 113(1):58-66. PubMed ID: 2909651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The physical state of hemoglobin in sickle-cell anemia erythrocytes in vivo.
    Döbler J; Bertles JF
    J Exp Med; 1968 Apr; 127(4):711-4. PubMed ID: 5642466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisickling effects of 2,3-diphosphoglycerate depletion.
    Poillon WN; Kim BC; Labotka RJ; Hicks CU; Kark JA
    Blood; 1995 Jun; 85(11):3289-96. PubMed ID: 7756662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.